Keystone Wealth Services LLC trimmed its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 8.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,229 shares of the company’s stock after selling 194 shares during the quarter. Keystone Wealth Services LLC’s holdings in Procter & Gamble were worth $355,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of PG. Nuveen LLC purchased a new stake in shares of Procter & Gamble in the first quarter worth about $1,954,941,000. GAMMA Investing LLC raised its stake in Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company’s stock valued at $1,355,087,000 after purchasing an additional 7,913,335 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Invesco Ltd. raised its stake in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Procter & Gamble in the fourth quarter valued at approximately $310,679,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on PG shares. Wells Fargo & Company lowered their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. BNP Paribas reaffirmed an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Berenberg Bank raised their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $173.94.
Insiders Place Their Bets
In other Procter & Gamble news, insider Susan Street Whaley sold 1,000 shares of the firm’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $156.84, for a total value of $156,840.00. Following the sale, the insider owned 28,436 shares of the company’s stock, valued at $4,459,902.24. This trade represents a 3.40% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary A. Coombe sold 10,194 shares of the firm’s stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the sale, the chief executive officer directly owned 34,978 shares in the company, valued at approximately $5,532,120.48. This trade represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Stock Up 1.3%
Shares of NYSE PG opened at $160.15 on Thursday. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The firm’s 50 day simple moving average is $156.20 and its two-hundred day simple moving average is $161.61. The stock has a market capitalization of $374.83 billion, a P/E ratio of 24.60, a PEG ratio of 4.17 and a beta of 0.36.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same period last year, the business earned $1.40 earnings per share. The business’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s dividend payout ratio (DPR) is 64.82%.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Consumer Discretionary Stocks Explained
- Biotech Breakouts: 3 Stocks With Massive Upside Potential
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Powering Up: A Buy Rating Signals GE Vernova’s AI Tailwinds
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The Side of Rate Cuts Nobody Is Telling You About
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.